Company profile

Ticker
LMNX
Exchange
CEO
Nachum Shamir
Employees
Incorporated in
Location
Fiscal year end
SEC CIK
IRS number
742747608

LMNX stock data

(
)

Calendar

5 Nov 19
18 Nov 19
31 Dec 19

News

Company financial data Financial data

Quarter (USD) Sep 19 Jun 19 Mar 19 Dec 18
Revenue 78.67M 83.06M 82.41M 81.13M
Net income -5.25M -4.93M 2.96M -2.3M
Diluted EPS -0.12 -0.11 0.07 -0.05
Net profit margin -6.67% -5.94% 3.59% -2.83%
Operating income -5.72M -5.76M -3.58M 968K
Net change in cash 2.73M 1.64M -14.75M -70.45M
Cash on hand 66.05M 63.33M 61.69M 76.44M
Cost of revenue 36.83M 37.83M 36.6M 32.79M
Annual (USD) Dec 18 Dec 17 Dec 16 Dec 15
Revenue 315.82M 306.57M 270.64M 237.71M
Net income 18.51M 29.42M 13.81M 36.86M
Diluted EPS 0.41 0.67 0.32 0.86
Net profit margin 5.86% 9.60% 5.10% 15.51%
Operating income 27.85M 37.15M 20.99M 37.36M
Net change in cash -50.67M 33.66M -35.09M 36.85M
Cash on hand 76.44M 127.11M 93.45M 128.55M
Cost of revenue 120.33M 107.53M 90.98M 69M

Financial data from Luminex earnings reports

Financial report summary

?
Management Discussion
  • Total revenue increased by 9% to $78.7 million for the three months ended September 30, 2019 from $72.4 million for the comparable period in 2018. The Company experienced increases in system sales, consumable sales, royalty revenue and service revenue, mainly attributable to the addition of our newly acquired flow cytometry business, which comprised 11% of total revenue in the third quarter of 2019. Excluding the impact of the Acquisition, revenue decreased 3% from the prior year quarter, primarily attributable to the decrease in LabCorp sales in non-automated assays. Assay revenue overall declined 13%, driven by decreases in our non-automated assay revenue, partially offset by increases in our automated assay revenue. Non-automated assay revenue comprised 46% of total assay revenue for the three months ended September 30, 2019 compared to 64% for the comparable period in 2018. Automated assay revenue, which consists of VERIGENE and ARIES® assays, grew 26% to $15.5 million for the three months ended September 30, 2019 from the comparable period in 2018.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: decision, larger, legacy, ownership, power, seat, unilateral
Removed: provisional, support